ELI LILLY & Co EPS (Diluted) 2008-2026 | LLY
Beta
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is ELI LILLY & Co's current eps (diluted)?
ELI LILLY & Co (LLY) annual eps (diluted) for 2025 was $22.95, a 95.99% increase from 2024. ELI LILLY & Co eps (diluted) for the quarter ending March 31, 2026 was $8.26.
What was ELI LILLY & Co's eps (diluted) in 2024?
ELI LILLY & Co annual eps (diluted) for 2024 was $11.71, a 101.90% increase from 2023.
What was ELI LILLY & Co's eps (diluted) in 2023?
ELI LILLY & Co annual eps (diluted) for 2023 was $5.80, a 15.94% decline from 2022.
What is ELI LILLY & Co's 5-year eps (diluted) CAGR?
ELI LILLY & Co eps (diluted) grew at a compound annual growth rate (CAGR) of 27.58% from FY2020 to FY2025, going from $6.79 to $22.95 over 5 years.
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+27.6%
FY2020
$6.79
→
FY2025
$22.95
080910111213141516171819202122232425
5 years selected
EPS (Diluted) History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $22.95 | +96.0% | 10-K |
| FY2024 | $11.71 | +101.9% | 10-K |
| FY2023 | $5.80 | -15.9% | 10-K |
| FY2022 | $6.90 | +12.7% | 10-K |
| FY2021 | $6.12 | -9.9% | 10-K |
| FY2020 | $6.79 | -23.6% | 10-K |
| FY2019 | $8.89 | +184.0% | 10-K |
| FY2018 | $3.13 | +1747.4% | 10-K |
| FY2017 | $-0.19 | -107.4% | 10-K |
| FY2016 | $2.58 | +14.2% | 10-K |
| FY2015 | $2.26 | +1.3% | 10-K |
| FY2014 | $2.23 | -48.4% | 10-K |
| FY2013 | $4.32 | +18.0% | 10-K |
| FY2012 | $3.66 | -6.2% | 10-K |
| FY2011 | $3.90 | -14.8% | 10-K |
| FY2010 | $4.58 | +16.2% | 10-K |
| FY2009 | $3.94 | +308.5% | 10-K |
| FY2008 | $-1.89 | - | 10-K |
Company: ELI LILLY & CoTicker: LLYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →